Bioject Medical Technologies Inc. (OTCMKTS:BJCT) M
Post# of 9
Posted On: 02/18/2015 12:52:21 PM
Bioject Medical Technologies Inc. (OTCMKTS:BJCT) Makes Change In The Core Management Team
BY LYLE MILLIGAN • FEBRUARY 13, 2015
Science and improved information technology have brought many changes; one of them is needle-free injection therapy system. Amongst a few companies that develop this system, Bioject Medical Technologies Inc. (OTCMKTS:BJCT) shares a prominent place. As per the reports, BJCT has announced a major change in its management team.
Insights on the matter:
The biggest change in the management has been introduced at the top. Bioject Medical Technologies Inc. (OTCMKTS:BJCT) has appointed Mr. Tony Chow as the new CEO and President. Previously, he worked as the Chief Financial Officer of the company. Before his journey with BJCT began, Mr. Chow was the CFO of American Laser Healthcare Corporation, a well-known development stage medical device organization, with SEC reporting. His experience goes past 30 years, with expertise in financial management consulting and financial operations. He has rendered services in various fields such as financial/JSOX/IT compliance, SEC reporting, business development, software product development/implementations, and client relationship management.
The first senior management role came his way in 1989 when he was appointed as the Controller of InterTherapy, Inc., a promising start-up company. It was famous for manufacturing and marketing of intravascular catheter and caterer ultrasound imaging system. After a successful tenure at InterTherapy Inc., he joined Craig Consumer Electronics, Inc. in 1994 as Chief Financial Officer and Corporate Controller, and worked there until 1997. He served as Director of Asia sales at Digital Video Systems, Inc for the next two years before moving to his next assignment.
After being promoted, Mr. Chow stated that his main focus would be to expand the business of Bioject Medical Technologies Inc. (OTCMKTS:BJCT) in Asia and other international locations. He also mentioned Mark Logomasini, Director of Business Development, saying that he would seek his cooperation in expanding BJCT on domestic and international locations. According to him, the year 2015 is going to be very critical for him in terms of fulfilling stakeholders’ expectations.
http://traders350.com/bioject-medical-technol...am/721169/
BY LYLE MILLIGAN • FEBRUARY 13, 2015
Science and improved information technology have brought many changes; one of them is needle-free injection therapy system. Amongst a few companies that develop this system, Bioject Medical Technologies Inc. (OTCMKTS:BJCT) shares a prominent place. As per the reports, BJCT has announced a major change in its management team.
Insights on the matter:
The biggest change in the management has been introduced at the top. Bioject Medical Technologies Inc. (OTCMKTS:BJCT) has appointed Mr. Tony Chow as the new CEO and President. Previously, he worked as the Chief Financial Officer of the company. Before his journey with BJCT began, Mr. Chow was the CFO of American Laser Healthcare Corporation, a well-known development stage medical device organization, with SEC reporting. His experience goes past 30 years, with expertise in financial management consulting and financial operations. He has rendered services in various fields such as financial/JSOX/IT compliance, SEC reporting, business development, software product development/implementations, and client relationship management.
The first senior management role came his way in 1989 when he was appointed as the Controller of InterTherapy, Inc., a promising start-up company. It was famous for manufacturing and marketing of intravascular catheter and caterer ultrasound imaging system. After a successful tenure at InterTherapy Inc., he joined Craig Consumer Electronics, Inc. in 1994 as Chief Financial Officer and Corporate Controller, and worked there until 1997. He served as Director of Asia sales at Digital Video Systems, Inc for the next two years before moving to his next assignment.
After being promoted, Mr. Chow stated that his main focus would be to expand the business of Bioject Medical Technologies Inc. (OTCMKTS:BJCT) in Asia and other international locations. He also mentioned Mark Logomasini, Director of Business Development, saying that he would seek his cooperation in expanding BJCT on domestic and international locations. According to him, the year 2015 is going to be very critical for him in terms of fulfilling stakeholders’ expectations.
http://traders350.com/bioject-medical-technol...am/721169/
(0)
(0)